@article {Darling2020.04.29.20084277, author = {Andrea L. Darling and Kourosh R. Ahmadi and Kate A Ward and Nicholas C Harvey and Alexessander Couto Alves and Deborah K. Dunn-Walters and Susan A. Lanham-New and Cyrus Cooper and David J. Blackbourn}, title = {Vitamin D status, body mass index, ethnicity and COVID-19: Initial analysis of the first-reported UK Biobank COVID-19 positive cases (n 580) compared with negative controls (n 723)}, elocation-id = {2020.04.29.20084277}, year = {2020}, doi = {10.1101/2020.04.29.20084277}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {In this short report we present a preliminary assessment of the serum 25-hydroxyvitamin D status (25(OH)D), body mass index (BMI), ethnicity and other lifestyle factors in the first-reported UK Biobank COVID-19 positive cases (n 580) compared with negative controls (n 723). The COVID-19 cases include those who have been treated as a hospital inpatient as well as those who have not, and are from England only. Mean (SD) for age was 57.5 (8.7) in positive cases and 57.9 (8.7) in negative controls.Competing Interest StatementCC reports consultancy, lecture fees and honoraria from AMGEN, GSK, Alliance for Better Bone Health, MSD, Eli Lilly, Pfizer, Novartis, Servier, Medtronic and Roche outside the scope of the submitted work. NCH reports consultancy, lecture fees and honoraria from Alliance for Better Bone Health, AMGEN, MSD, Eli Lilly, Servier, Shire, UCB, Kyowa Kirin, Consilient Healthcare, Radius Health and Internis Pharma outside the scope of the submitted work. SLN reports honoraria for two conference talks from Thornton \& Ross, consultancy for General Mills and is Research Director of D3Tex Ltd which holds the UK and GCC Patents for the use of UVB material for prevention ofvitamin D deficiency. These are outside of the submitted work. KAW is a Royal Osteoporosis Society member of the Nutrition and Lifestyle Forum, American Society for Bone and Mineral Research Council member and International Osteoporosis Foundation member of the Committee for Scientific Advisors. All other authors report no conflict of interest.Clinical TrialNot applicableFunding StatementThis work was supported by in-house funds from the University of Surrey for payment of the UK Biobank access fee. The UK Biobank was established by the Wellcome Trust medical charity, Medical Research Council, Department of Health, Scottish Government and the Northwest Regional Development Agency. It has also had funding from the Welsh Assembly Government and the British Heart Foundation. UK Biobank is hosted by the University of Manchester and supported by the National Health Service (NHS). All the above funders had no role in the design, analysis or writing of the present study.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is available from the UK Biobank directly- the authors are not authorised to provide this to others.}, URL = {https://www.medrxiv.org/content/early/2020/05/05/2020.04.29.20084277}, eprint = {https://www.medrxiv.org/content/early/2020/05/05/2020.04.29.20084277.full.pdf}, journal = {medRxiv} }